Author: gwenj9281442
Canada – Health Canada authorizes Novavax’s Nuvaxovid COVID-19 vaccine
Statement Health Canada has authorized Novavax’s Nuvaxovid COVID-19 vaccine for the prevention of COVID-19 in adults 18 years of age and older. February 17, 2022 – Ottawa, ON – Health Canada Today, Health Canada authorized Novavax’s Nuvaxovid COVID-19 vaccine for the prevention of COVID-19 in adults 18 years of age and older. This is the fifth COVID-19 vaccine authorized in Canada. After a thorough, independent review of the evidence, the Department has determined that this vaccine meets Canada’s stringent safety, efficacy and quality requirements. Nuvaxovid is a protein-based vaccine that is administered as a two-dose regimen of 5 mcg per ... Read more